{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:02:36Z","timestamp":1779930156623,"version":"3.53.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Synaptotagmin-2\u2013related disease is an ultrarare entity, characterized by distal muscle atrophy in the lower limbs, foot deformities and, in some cases, neonatal hypotonia. Most mutations are concentrated in the C2B domain, critical for the protein's function. Here, our objective is to review clinical, electrophisiological and pathological aspects of this disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We describe a previously unreported variant, comparing it with another 27 cases described in the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A 14-year-old boy was born with neonatal hypotonia, weak cry, and dysphonia. During childhood, he had recurrent respiratory infections, delayed motor development, and developed glaucoma. Creatine phosphokinase level was 501 U\/L; EMG showed reduced compound muscle action potential, myopathic findings, and incremental response. A comprehensive next-generation sequence panel revealed a homozygous variant in the\n                      <jats:italic toggle=\"yes\">SYT2<\/jats:italic>\n                      gene.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      The data summarized here and our case provide a general characterization of the phenotypic spectrum of\n                      <jats:italic toggle=\"yes\">SYT2<\/jats:italic>\n                      -related disease and point out to its electrophysiological and pathological features. We discuss the intriguing aspects of a neuromuscular junction disease considered as a distal hereditary motor neuropathy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cnd.0000000000000508","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:00:17Z","timestamp":1764738017000},"page":"45-56","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["SYT2-Related Disease: A Case-Based Review"],"prefix":"10.1097","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3467-7613","authenticated-orcid":false,"given":"Pedro Nogueira","family":"Fontana","sequence":"first","affiliation":[{"name":"Department of Neurology, Hospital Universit\u00e1rio Oswaldo Cruz, Universidade de Pernambuco, Recife, PE, Brazil; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina da Cunha","family":"Correia","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universit\u00e1rio Oswaldo Cruz, Universidade de Pernambuco, Recife, PE, Brazil; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3841-3112","authenticated-orcid":false,"given":"Ana Marina Dutra","family":"Ferreira da Silva","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Servi\u00e7o Neuromuscular, Faculdade de Medicina do ABC, Centro Universit\u00e1rio FMABC, Santo Andr\u00e9, SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alzira Alves de Siqueira","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Servi\u00e7o Neuromuscular, Faculdade de Medicina do ABC, Centro Universit\u00e1rio FMABC, Santo Andr\u00e9, SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251203","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/2042098618792502","article-title":"Pharmacovigilance of medicines for rare and ultrarare diseases","volume":"9","author":"Sardella","year":"2018","journal-title":"Ther Adv Drug Saf"},{"key":"R2-20251203","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ajhg.2014.08.007","article-title":"Synaptotagmin 2 mutations cause an autosomal-dominant form of Lambert-Eaton myasthenic syndrome and nonprogressive motor neuropathy","volume":"95","author":"Herrmann","year":"2014","journal-title":"Am J Hum Genet"},{"key":"R3-20251203","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1212\/WNL.0000000000002185","article-title":"Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome","volume":"85","author":"Whittaker","year":"2015","journal-title":"Neurology"},{"key":"R4-20251203","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1212\/NXG.0000000000000282","article-title":"Identification of a new SYT2 variant validates an unusual distal motor neuropathy phenotype","volume":"4","author":"Montes-Chinea","year":"2018","journal-title":"Neurol Genet"},{"key":"R5-20251203","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1212\/NXG.0000000000000534","article-title":"New recessive mutations in SYT2 causing severe presynaptic congenital myasthenic syndromes","volume":"6","author":"Bauch\u00e9","year":"2020","journal-title":"Neurol Genet"},{"key":"R6-20251203","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/jns.12425","article-title":"A new de novo SYT2 mutation presenting as distal weakness. Neuropathy or neuromuscular junction dysfunction?","volume":"26","author":"Fionda","year":"2020","journal-title":"J Peripher Nervous Syst"},{"key":"R7-20251203","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/ajmg.a.61765","article-title":"Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome","volume":"182","author":"Donkervoort","year":"2020","journal-title":"Am J Med Genet A"},{"key":"R8-20251203","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/ajmg.a.61579","article-title":"Recessive congenital myasthenic syndrome caused by a homozygous mutation in SYT2 altering a highly conserved C-terminal amino acid sequence","volume":"182","author":"Maselli","year":"2020","journal-title":"Am J Med Genet A"},{"key":"R9-20251203","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mus.27332","article-title":"Dominant and recessive congenital myasthenic syndromes caused by SYT2 mutations","volume":"64","author":"Maselli","year":"2021","journal-title":"Muscle Nerve"},{"key":"R10-20251203","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3390\/genes11111238","article-title":"Identification of a Novel de Novo variant in the SYT2 gene causing a rare type of distal hereditary motor neuropathy","volume":"11","author":"Mironovich","year":"2020","journal-title":"Genes (Basel)"},{"key":"R11-20251203","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12041-022-01409-3","article-title":"Exome sequencing and microarray identified a novel large exonic deletion in SYT2 gene in an ultra-rare case with recessive CMS type 7","volume":"102","author":"Kumar","year":"2023","journal-title":"J Genet"},{"key":"R13-20251203","doi-asserted-by":"crossref","first-page":"13493","DOI":"10.1523\/JNEUROSCI.3519-06.2006","article-title":"Synaptotagmin-2 is essential for survival and contributes to Ca2+ triggering of neurotransmitter release in central and neuromuscular synapses","volume":"26","author":"Pang","year":"2006","journal-title":"J Neurosci"},{"key":"R14-20251203","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/0092-8674(93)90733-7","article-title":"Mutational analysis of Drosophila synaptotagmin demonstrates its essential role in Ca(2+)-activated neurotransmitter release","volume":"74","author":"Littleton","year":"1993","journal-title":"Cell"},{"key":"R15-20251203","doi-asserted-by":"crossref","first-page":"13548","DOI":"10.1016\/S0021-9258(18)92733-X","article-title":"Synaptotagmin II. A novel differentially distributed form of synaptotagmin","volume":"266","author":"Geppert","year":"1991","journal-title":"J Biol Chem"},{"key":"R16-20251203","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1007\/s00018-008-8352-3","article-title":"Membrane fusion: SNAREs and regulation","volume":"65","author":"Malsam","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"R17-20251203","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1126\/science.1161748","article-title":"Membrane fusion: grappling with SNARE and SM proteins","volume":"323","author":"S\u00fcdhof","year":"2009","journal-title":"Science"},{"key":"R20-20251203","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0896-6273(00)80171-3","article-title":"Synaptotagmins: C2-domain proteins that regulate membrane traffic","volume":"17","author":"S\u00fcdhof","year":"1996","journal-title":"Neuron"},{"key":"R21-20251203","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1523\/JNEUROSCI.3214-12.2013","article-title":"Genetic analysis of synaptotagmin C2 domain specificity in regulating spontaneous and evoked neurotransmitter release","volume":"33","author":"Lee","year":"2013","journal-title":"J Neurosci"},{"key":"R22-20251203","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ncl.2018.01.008","article-title":"Lambert-Eaton myasthenic syndrome","volume":"36","author":"Kesner","year":"2018","journal-title":"Neurol Clin"},{"key":"R23-20251203","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis","volume":"129","author":"Farrugia","year":"2006","journal-title":"Brain"},{"key":"R24-20251203","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/CND.0000000000000171","article-title":"Triple furrowed atrophic tongue of myasthenia gravis","volume":"19","author":"Young","year":"2017","journal-title":"J Clin Neuromuscul Dis"},{"key":"R25-20251203","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1212\/WNL.0000000000008076","article-title":"Reversible tongue atrophy in Lambert-Eaton myasthenic syndrome","volume":"93","author":"Cammaert","year":"2019","journal-title":"Neurology"},{"key":"R26-20251203","doi-asserted-by":"crossref","first-page":"e200056","DOI":"10.1212\/NXG.0000000000200056","article-title":"Clinical manifestation of nebulin-associated nemaline myopathy","volume":"9","author":"Moreno","year":"2023","journal-title":"Neurol Genet"},{"key":"R27-20251203","doi-asserted-by":"crossref","first-page":"677","DOI":"10.5692\/clinicalneurol.cn-001365","article-title":"A case of thyrotoxic myopathy with generalized body muscular atrophy including the tongue muscle, lacking physical manifestations of Basedow disease","volume":"60","author":"Kitahara","year":"2020","journal-title":"Rinsho Shinkeigaku"},{"key":"R28-20251203","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp.50.4.476","article-title":"Congenital Lambert-Eaton myasthenic syndrome","volume":"50","author":"Bady","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R29-20251203","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/mus.10269","article-title":"Congenital myasthenic syndromes: progress over the past decade","volume":"27","author":"Engel","year":"2003","journal-title":"Muscle Nerve"},{"key":"R30-20251203","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12017-018-8490-1","article-title":"How to spot congenital myasthenic syndromes resembling the Lambert\u2013Eaton myasthenic syndrome? A brief review of clinical, electrophysiological, and genetics features","volume":"20","author":"Lorenzoni","year":"2018","journal-title":"Neuromolecular Med"},{"key":"R31-20251203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000427","article-title":"Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission","volume":"9","author":"M\u00fcller","year":"2007","journal-title":"Expert Rev Mol Med"},{"key":"R32-20251203","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ajhg.2012.09.019","article-title":"Defective presynaptic choline transport underlies hereditary motor neuropathy","volume":"91","author":"Barwick","year":"2012","journal-title":"Am J Hum Genet"},{"key":"R33-20251203","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/ng.3703","article-title":"M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity","volume":"48","author":"Jagadeesh","year":"2016","journal-title":"Nat Genet"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:00:21Z","timestamp":1764738021000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0000000000000508","relation":{},"ISSN":["1522-0443","1537-1611"],"issn-type":[{"value":"1522-0443","type":"print"},{"value":"1537-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}